Dihydromyricetin protects against Doxorubicin-induced cardiotoxicity through activation of AMPK/mTOR pathway
Xiaoqi LiDepartment of Blood Transfusion and Laboratory Medicine, Fourth Affiliated Hospital of Harbin Medical University, Harbin, ChinaXin WangDepartment of Blood Transfusion and Laboratory Medicine, Fourth Affiliated Hospital of Harbin Medical University, Harbin, ChinaBinyu WangDepartment of Blood Transfusion and Laboratory Medicine, Fourth Affiliated Hospital of Harbin Medical University, Harbin, ChinaWei-Qun ChiDepartment of Blood Transfusion and Laboratory Medicine, Fourth Affiliated Hospital of Harbin Medical University, Harbin, ChinaZhangyi LiDepartment of Biochemistry and Life Sciences, Faculty of Arts and Sciences, Queen's University, Kingston, Ontario, CanadaMin ZhangDepartment of Blood Transfusion and Laboratory Medicine, Fourth Affiliated Hospital of Harbin Medical University, Harbin, ChinaYifu ShenDepartment of Blood Transfusion and Laboratory Medicine, Fourth Affiliated Hospital of Harbin Medical University, Harbin, ChinaXu LiuDepartment of Blood Transfusion and Laboratory Medicine, Fourth Affiliated Hospital of Harbin Medical University, Harbin, ChinaYoumei LuFourth Affiliated Hospital of Harbin Medical UniversityYu LiuDepartment of Blood Transfusion and Laboratory Medicine, Fourth Affiliated Hospital of Harbin Medical University, Harbin, China. Electronic address: [email protected]
2022en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0